Woodline Partners
Woodline Partners is a private equity firm that focuses on the healthcare and technology sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Woodline Partners Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$967M
Social
Linkedin
Crunchbase
Metrics
2,488,838Website Global Rank
7,261Website Monthly Traffic
Twitter Followers
Description
Woodline Partners is a private equity firm that focuses on the healthcare and technology sectors. The firm was founded in 2018 and is based in San Francisco, California, United States.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2021 | Frontier Medicines | Series B | 0 |
| 9/2021 | LEXEO Therapeutics | Series B | 0 |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 6/2021 | Talkspace | Post-IPO Equity | 0 |
| 10/2022 | Odyssey Therapeutics | Series B | 0 |
| 7/2021 | Sharecare | Post-IPO Equity | 0 |
| 5/2021 | NeoGenomics | Post-IPO Equity | 0 |
| 9/2021 | SmartNews | Series F | 0 |
| 5/2021 | HydraFacial | Post-IPO Equity | 0 |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 1/2021 | LEXEO Therapeutics | Series A | 0 |
| 7/2019 | Frontier Medicines | Series B | 88.5M |
| 2/2021 | Vividion Therapeutics | Series C | 135M |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
| 7/2021 | Kriya Therapeutics | Series B | 0 |
| 12/2021 | Odyssey Therapeutics | Series A | 0 |
| 1/2022 | Maze Therapeutics | Venture Round | 0 |
| 3/2023 | Orchard Therapeutics | Post-IPO Equity | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2022 | Ventyx Biosciences | Post-IPO Equity | 0 |
| 10/2021 | Cedilla Therapeutics | Series B | 0 |
| 4/2021 | Patreon | Series F | 155M |
| 5/2023 | ElevateBio | Series D | 0 |
| 8/2020 | Kronos Bio | Private Equity Round | 155M |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 8/2021 | Tango Therapeutics | Post-IPO Equity | 0 |
| 7/2021 | Point Biopharma | Post-IPO Equity | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 9/2020 | Eledon Pharmaceuticals | Post-IPO Equity | 108M |
| 1/2021 | Scorpion Therapeutics | Series B | 162M |
| 5/2023 | Lyra Therapeutics | Post-IPO Equity | 0 |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 1/2022 | Maze Therapeutics | Venture Round | 0 |
| 12/2021 | Odyssey Therapeutics | Series A | 0 |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 10/2021 | Cedilla Therapeutics | Series B | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 9/2021 | SmartNews | Series F | 0 |
| 9/2021 | LEXEO Therapeutics | Series B | 0 |
| 8/2021 | Tango Therapeutics | Post-IPO Equity | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
